Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis.
Neurofibromatosis is sometimes complicated by impaired renal tubular reabsorption of phosphate, hypophosphatemia, and osteomalacia. Hyperparathyroidism has also been reported in patients with neurofibromatosis. When hypercalcemia and elevated levels of parathyroid hormone are found in osteomalacia, however, it may be difficult to determine if the hyperparathyroidism was primary or tertiary. We describe a patient with neurofibromatosis, hypercalcemic hyperparathyroidism, hypophosphatemic osteomalacia, vitamin D deficiency, and clear-cell hyperplasia of all four parathyroid glands. Serial biomechanical, bone biopsy, and densitometric studies confirmed that treatment with ergocalciferol, calcium, and phosphate supplements significantly improved the osteomalacia but caused increased parathyroid overactivity. After subtotal parathyroidectomy, the parathyroid hormone concentration became normal and the bone mineral content increased at the spine and hip, but inappropriate phosphaturia persisted. The findings indicate that hyperparathyroidism, osteomalacia, and vitamin D deficiency adversely affect each other.
Weinstein
R S
RS
Department of Medicine, Medical College of Georgia, Augusta 30912.
Harris
R L
RL
D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D003720:Densitometry; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D006961:Hyperparathyroidism / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D009456:Neurofibromatosis 1 / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D010018:Osteomalacia / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D010710:Phosphates / Q000097:blood*
D010710:Phosphates